PubTransformer

A site to transform Pubmed publications into these bibliographic reference formats: ADS, BibTeX, EndNote, ISI used by the Web of Knowledge, RIS, MEDLINE, Microsoft's Word 2007 XML.

Thyroid-associated orbitopathy in patients with thyroid carcinoma: A case report of 5 cases.

Abstract Thyroid-associated orbitopathy (TAO) is most often seen in patients with autoimmune thyroid disease. Data about TAO occurred in patients with thyroid carcinoma are rare. We give a report of 5 patients to present the clinical characteristics, treatment, and prognosis of this type of case.
PMID
Related Publications

Time course of Graves' ophthalmopathy after total thyroidectomy alone or followed by radioiodine therapy: a 2-year longitudinal study.

Long-term multidisciplinary follow-up of unilateral thyroid-associated orbitopathy.

Papillary thyroid carcinoma with thyroid-associated orbitopathy in a euthyroid state.

Graves' ophthalmopathy after total thyroidectomy for papillary carcinoma.

Development of Thyroid-Associated Ophthalmopathy in Patients Who Underwent Total Thyroidectomy.

Authors

Mayor MeshTerms
Keywords
Journal Title medicine
Publication Year Start




PMID- 29381976
OWN - NLM
STAT- MEDLINE
DCOM- 20180208
LR  - 20180208
IS  - 1536-5964 (Electronic)
IS  - 0025-7974 (Linking)
VI  - 96
IP  - 47
DP  - 2017 Nov
TI  - Thyroid-associated orbitopathy in patients with thyroid carcinoma: A case report 
      of 5 cases.
PG  - e8768
LID - 10.1097/MD.0000000000008768 [doi]
AB  - RATIONALE: Thyroid-associated orbitopathy (TAO) is most often seen in patients
      with autoimmune thyroid disease. Data about TAO occurred in patients with thyroid
      carcinoma are rare. We give a report of 5 patients to present the clinical
      characteristics, treatment, and prognosis of this type of case. PATIENT CONCERNS:
      Five thyroid carcinoma patients presented with orbitopathy. Among them, two
      patients (patient 1 and 4) were hyperthyroid and TSH receptor antibody (TRAb)
      positive, two patients (patient 3 and 5) were euthyroid and displayed slightly
      elevated TRAb titres, one patient (patient 2) was euthyroid and TRAb negative.
      DIAGNOSES: They were diagnosed as thyroid carcinoma and TAO. INTERVENTIONS:
      Patient 1 underwent total thyroidectomy, intravenous glucocorticoids (GCs)
      therapy, orbital decompression surgery and oral GCs therapy. Patient 2 and 3 only
      received total thyroidectomy. Patient 4 received sub-total thyroidectomy and oral
      GCs therapy. patient 5 didn't received thyroidectomy and underwent intravenous
      GCs therapy for 2 courses. OUTCOMES: Patient 1,2,3 showed an improvement of TAO
      at the final follow-up. Patient 4,5 showed no improvement of TAO at the final
      follow-up. LESSONS: When TAO present in patients with thyroid nodules, the
      possibility of thyroid carcinoma should be considered, and the nature of these
      nodules should be carefully evaluated. In some patients with thyroid carcinoma
      and TAO, the remission of TAO can be seen post total thyroidectomy. But for other
      patients, besides thyroidectomy, an adequate dose and course of intravenous GCs
      treatment and even ocular surgery are also needed.
CI  - Copyright (c) 2017 The Authors. Published by Wolters Kluwer Health, Inc. All
      rights reserved.
FAU - Yu, Peng
AU  - Yu P
AD  - Department of Internal Medicine.
FAU - Liu, Siyue
AU  - Liu S
AD  - Department of Internal Medicine.
FAU - Zhou, Xinrong
AU  - Zhou X
AD  - Department of Internal Medicine.
FAU - Huang, Teng
AU  - Huang T
AD  - Department of Internal Medicine.
FAU - Li, Yaling
AU  - Li Y
AD  - Department of Internal Medicine.
FAU - Wang, Hong
AU  - Wang H
AD  - Molecular Diagnostic Laboratory, Tongji Hospital, Huazhong University of Science 
      and Technology, Wuhan, Hubei, China.
FAU - Yuan, Gang
AU  - Yuan G
AD  - Department of Internal Medicine.
LA  - eng
PT  - Case Reports
PT  - Journal Article
PL  - United States
TA  - Medicine (Baltimore)
JT  - Medicine
JID - 2985248R
RN  - 0 (Glucocorticoids)
RN  - 0 (Receptors, Thyrotropin)
SB  - AIM
SB  - IM
MH  - Adult
MH  - Female
MH  - Glucocorticoids/therapeutic use
MH  - Graves Ophthalmopathy/*etiology/pathology/therapy
MH  - Humans
MH  - Male
MH  - Middle Aged
MH  - Orbit/pathology
MH  - Orbital Diseases/*etiology/pathology/therapy
MH  - Receptors, Thyrotropin/immunology
MH  - Thyroid Neoplasms/*complications/pathology/therapy
MH  - Thyroidectomy
PMC - PMC5708975
EDAT- 2018/02/01 06:00
MHDA- 2018/02/09 06:00
CRDT- 2018/02/01 06:00
PHST- 2018/02/01 06:00 [entrez]
PHST- 2018/02/01 06:00 [pubmed]
PHST- 2018/02/09 06:00 [medline]
AID - 10.1097/MD.0000000000008768 [doi]
AID - 00005792-201711270-00067 [pii]
PST - ppublish
SO  - Medicine (Baltimore). 2017 Nov;96(47):e8768. doi: 10.1097/MD.0000000000008768.